{
  "updated": "2026-11-21",
  "sources": [
    {"id":"a24","title":"A24: You Can See Everything","url":"https://a24films.com/films/you-can-see-everything","kind":"Distributor synopsis and credits","locator":"Details and Directed By sections","inspected":"Selected synopsis and director credits inspected on 21 November 2026","limit":"Promotional production account, not a scene transcript or independent identification of an engineer."},
    {"id":"idfa","title":"IDFA 2026: You Can See Everything","url":"https://festival.idfa.nl/en/film/715217e7-beea-4efa-b608-600b0caf2636/you-can-see-everything/","kind":"Festival programme","locator":"Synopsis and credits; runtime 174 min","inspected":"Selected synopsis, runtime and director credits inspected on 21 November 2026","limit":"Programme runtime does not authenticate the edition, scene times or all recording/performance boundaries."},
    {"id":"appeal-2025","title":"United States v Holmes and Balwani: order and amended opinion, 22 December 2025","url":"https://cdn.ca9.uscourts.gov/datastore/opinions/2025/12/22/23-1040.pdf","kind":"Appellate judicial opinion recounting trial evidence","locator":"Printed pp11–13 / PDF pp11–13; Peterson and financial evidence; cover identifies amended date","inspected":"Selected cover and factual-background passages, not a full appellate/legal-status audit","limit":"A judicial account of selected trial evidence is not a complete witness transcript, investment file or cash ledger. Do not infer the current status of every proceeding."},
    {"id":"exhibit-15031","title":"United States v Holmes: Trial Exhibit 15031, internal email and financial attachment","url":"https://files.cand.uscourts.gov/files/18-CR-258%20USA%20v.%20Holmes/Trial%20Exh.%2015031/Trial%20Exh.%2015031%20Email.pdf","kind":"Public trial exhibit: internal email, projections and reported balance sheet","locator":"PDF p1 email dated 15 July 2014; p2 HOLMES0019226; p3 HOLMES0019227; p4 HOLMES0019228","inspected":"Email metadata extracted; all three financial pages visually checked on 21 November 2026","limit":"Company-produced statements, not an independent audit. Proforma/forecast figures are not actual expenditure; internal transmission does not establish delivery to an investor."},
    {"id":"kpbs-evans","title":"KPBS: Billy Evans and the San Diego roots of the film, 2 November 2026","url":"https://www.kpbs.org/news/arts-culture/2026/11/02/who-is-billy-evans-you-can-see-everything-san-diego","kind":"Reporting / indexed extract for the venture reference","locator":"Indexed passage referring to May 2025 coverage of Haemanthus","inspected":"Indexed extract inspected and article opened; not a full article audit","limit":"A reporting lead about the venture, not authentication of the remembered engineer or dialogue."},
    {"id":"haemanthus-application","title":"US20250277701A1: Raman spectroscopy system","url":"https://patents.google.com/patent/US20250277701A1/en","kind":"Published patent application, not a granted patent","locator":"Bibliographic record and opening Raman-system description","inspected":"Named inventors, publication identifier/date and selected technical description inspected on 21 November 2026","limit":"Database ownership/status labels are not a legal-title opinion. Does not identify the film speaker, prove employment or clinically validate a product."},
    {"id":"balwani-doj","title":"DOJ: Balwani conspiracy and wire-fraud verdict, 7 July 2022","url":"https://www.justice.gov/usao-ndca/pr/theranos-chief-operating-officer-ramesh-sunny-balwani-found-guilty-conspiracy-wire","kind":"Prosecution announcement of verdict","locator":"Opening verdict summary; executive role identified in title","inspected":"Opening verdict passages and indexed executive-role description inspected on 21 November 2026","limit":"A prosecution account, not the complete trial or subsequent appeal record. Balwani and Holmes had separate trials and verdicts."},
    {"id":"fielder-publicity","title":"HBO publicity: The Rehearsal, from Nathan Fielder","url":"https://press.wbd.com/us/media-release/hbo-0/rehearsal/hbo-comedy-series-rehearsal-nathan-fielder-debuts-july-15","kind":"Publicity / indexed search extract only","locator":"Search extract identifies Nathan For You and The Rehearsal","inspected":"Indexed title and synopsis extract only; direct page access returned 403 on 21 November 2026","limit":"Not a full-page inspection or an independent career analysis. Does not establish why Fielder was chosen for this film."},
    {"id":"flc","title":"Film at Lincoln Center: You Can See Everything","url":"https://www.filmlinc.org/nyff2026/films/you-can-see-everything/","kind":"Festival listing","locator":"Director, runtime and synopsis","inspected":"Listing and synopsis inspected on 21 November 2026","limit":"Promotional synopsis; not an authenticated transcript or complete credit/scene audit."},
    {"id":"participants","title":"David Fear: interview with Fielder, Oppenheim and Seyfried","url":"https://ca.rollingstone.com/tv-movies/amanda-seyfried-nathan-fielder-you-can-see-everything/","kind":"Participant account / edited interview","locator":"Introduction and discussion of Seyfried's involvement","inspected":"Selected passages inspected on 21 November 2026","limit":"Edited participant testimony, not independent verification of every scene or motive."},
    {"id":"sec","title":"SEC complaint against Holmes and Theranos, 14 March 2018","url":"https://www.sec.gov/files/litigation/complaints/2018/comp-pr2018-41-theranos-holmes.pdf","kind":"Civil allegations","locator":"Paragraphs 1–5 and 48–51; retain full document context","inspected":"Selected passages; not a complete exhibit audit","limit":"Allegations must not be relabelled as judicial findings; each investor's actual information requires separate evidence."},
    {"id":"sec-release","title":"SEC announcement 2018-41","url":"https://www.sec.gov/newsroom/press-releases/2018-41","kind":"Regulator account of allegations and settlement","locator":"Opening paragraphs; technology, revenue and resolution","inspected":"Announcement inspected on 21 November 2026","limit":"A civil settlement announcement is not a criminal verdict or a complete accounting ledger."},
    {"id":"doj","title":"DOJ: Holmes investor-fraud verdict, 4 January 2022","url":"https://www.justice.gov/usao-ndca/pr/theranos-founder-elizabeth-holmes-found-guilty-investor-fraud","kind":"Prosecution account of trial and mixed verdict","locator":"Verdict summary and account of trial evidence","inspected":"Selected verdict and evidence passages inspected","limit":"Read the verdict count by count. This is not the complete trial record or a finding that every allegation was proven."},
    {"id":"exhibit","title":"United States v Holmes: trial Exhibit 3696","url":"https://files.cand.uscourts.gov/files/18-CR-258%20USA%20v.%20Holmes/Trial%20Exh.%203696/Trial%20Exh.%203696%20Presentation.pdf","kind":"Contemporaneous presentation / trial exhibit","locator":"PDF page 3; page 8 reviewed earlier","inspected":"Page-level inspection, not the full delivery history","limit":"Wording is evidence of a representation, not demonstrated capability, authorship, delivery to a particular investor or all accompanying qualifications."},
    {"id":"jci","title":"Evaluation of direct-to-consumer low-volume lab tests in healthy adults (2016)","url":"https://www.jci.org/articles/view/86318","kind":"Peer-reviewed comparative study","locator":"Abstract and selected methods; 60 healthy adults, 22 tests","inspected":"Abstract and selected methods; not raw-data reanalysis","limit":"A delivered-service comparison, not a teardown establishing the internal instrument for every result, all assays or all patient groups."},
    {"id":"patent","title":"US8283155B2: Point-of-care fluidic systems and uses thereof","url":"https://patents.google.com/patent/US8283155B2/en","kind":"Granted patent record","locator":"Bibliographic record; granted claims 1–10, especially 1 and 9","inspected":"Selected granted claims and original-assignee/publication fields inspected on 21 November 2026; no validity or legal-title audit","limit":"A granted patent is not regulatory clearance or clinical validation; product-to-claim mapping remains unverified. Database ownership labels are not a legal opinion."},
    {"id":"minilab","title":"Theranos 2016 AACC technology announcement","url":"https://www.prnewswire.com/news-releases/theranos-unveils-its-diagnostic-testing-technologies-at-american-association-for-clinical-chemistry-meeting-300307117.html","kind":"Company announcement","locator":"2016 integrated-system description","inspected":"Previously linked company account; independent performance audit pending","limit":"Company descriptions are representations, not independent validation; do not project later architecture back onto earlier devices."}
  ],
  "claims": [
    {"id":"claim-now","question":"A working system now, or a possible future platform?","category":"investors","basis":"Document observation","presentation":"The film raises the distinction between a CEO's present-capability assertion and a statement of future potential. The exact film wording and timing still need checking.","evidence":"Exhibit 3696 page 3 uses present-tense language about running comprehensive tests from a finger-stick. The SEC separately alleges misleading investor materials and demonstrations.","qualification":"A presentation does not by itself prove who received it, the date, oral qualifications, test performance or a particular person's state of mind. Future-potential arguments must be matched to the same communication and recipient.","finding":"The claim must be tested at the date it was communicated, against the actual device, sample, assay menu and disclosures—not against later technical ambitions.","sources":["exhibit","sec"],"next":"Obtain each dated deck version, distribution evidence, demonstration protocol and relevant testimony; link the film scene without inventing a quotation."},
    {"id":"claim-platform","question":"Does one platform mean one method can do every blood test?","category":"technology","basis":"Technical analysis","presentation":"Platform can sound like a universal sensor. That interpretation needs evidence rather than assumption.","evidence":"An integrated platform can combine preparation, several detection modules and software. Blood-cell counting, immunoassays, chemistry and nucleic-acid tests do not become the same measurement because they share a housing.","qualification":"The 2016 company announcement describes a later proposed system. It does not validate earlier devices or prove clinical performance across the menu.","finding":"Ask what was integrated, which assays worked, and which sample/workflow was validated. An individual successful measurement cannot validate a whole platform.","sources":["minilab","jci"],"next":"Build a dated device-and-assay matrix, including external instruments and every manual/off-device step."},
    {"id":"claim-machines","question":"Was the promised proprietary device doing the patient testing?","category":"technology","basis":"Civil allegation / trial account","presentation":"The distinction is not simply whether a laboratory produced a number, but how that number was obtained.","evidence":"The SEC alleged that the proprietary analyzer supported few tests and that most patient testing used third-party commercial analyzers. The DOJ trial account also describes instrument limitations.","qualification":"These source types differ. Do not turn the SEC allegation into an assay-by-assay criminal finding or assume every test used the same instrument.","finding":"A service result, a proprietary-device result and a validated finger-prick result are different propositions.","sources":["sec-release","doj"],"next":"Match particular assays and dates to laboratory records and instrument logs before assigning a measurement to a device."},
    {"id":"claim-patent","question":"Did the intellectual property prove the invention worked?","category":"technology","basis":"Patent / evidential distinction","presentation":"Patented and proprietary can sound like technical verification when used in a pitch.","evidence":"US8283155B2 supplies a concrete starting specification and set of legal claims for a fluidic-system investigation.","qualification":"No full ownership chain, validity assessment or product-to-claim mapping has been completed here. Patent and clinical-validation questions are different.","finding":"Read the granted claims and relevant dates, then map them to the product and the capability represented to investors. Do not count a patent as an accuracy study.","sources":["patent","exhibit"],"next":"Record inventors, priority dates, assignees, claim scope and actual implementation separately."},
    {"id":"claim-verdict","question":"Does a guilty verdict establish every claim made about Theranos?","category":"law","basis":"Reported verdict","presentation":"A film discussion can collapse allegations, investor fraud, patient testing and business failure into a single conclusion.","evidence":"The DOJ records one investor-conspiracy conviction and three investor wire-fraud convictions, alongside acquittals and counts on which the jury did not reach a verdict.","qualification":"Neither conviction on some counts nor acquittal on others decides every scientific, historical or moral proposition. A prosecution summary is not the complete record.","finding":"State the actual result and the legal/source context; examine the underlying claim rather than treating a verdict as a universal fact-check.","sources":["doj"],"next":"Link relevant verdict forms, instructions and evidence for each specific claim, retaining defence qualifications."},
    {"id":"claim-nodding","question":"Can Holmes's nodding tell us whether she is truthful?","category":"film","basis":"Viewer question / unresolved observation","presentation":"A viewer recalls frequent nodding in the first portion of the film. Its frequency has not been measured here.","evidence":"No verified sequence coding, baseline behaviour or unedited footage has been inspected for this question.","qualification":"Listening, conversational timing, agreement, politeness, direction and editing are possible explanations—not conclusions about this person. A gesture is not a lie detector.","finding":"If studied, record observable behaviour and editing context; do not infer deceit, diagnosis or motive from it.","sources":[],"next":"Code a defined sequence with scene references and a stated counting method, keeping observation separate from interpretation."}
  ],
  "scenes": [
    {"id":"sequence-home","title":"Home access before incarceration","type":"Documentary access, according to festival synopsis","account":"The festival describes filming Holmes and Billy Evans at home before she entered prison. That supports the broad recording context, not a declaration that every moment in an entire half is unstaged.","sources":["flc"],"timecode":null,"verification":"Synopsis checked; individual shots and chronology not authenticated","question":"Who is present, when was each exchange recorded, and what did the edit omit?"},
    {"id":"sequence-performance","title":"Seyfried's involvement and the change of form","type":"Performance / participant account","account":"The participant interview identifies Seyfried's later involvement and a shift involving portrayal. This supports separating a performer from Holmes; it does not establish a clean, timed boundary between two wholly different kinds of footage.","sources":["participants"],"timecode":null,"verification":"Selected participant account checked; no frame-by-frame audit","question":"Which passages are performances, on what original material are they based, and how does the film disclose this?"},
    {"id":"sequence-engineer","title":"The engineer and 'the wrong technology'","type":"Viewer recollection; identity and wording unverified","account":"The remembered phrase is a research lead, not an authenticated quotation in this register. The speaker's identity, complete explanation and technical referent are still unknown.","sources":[],"timecode":null,"verification":"Not yet verified against the film","question":"Does 'wrong' refer to sample handling, detection chemistry, miniaturisation, throughput, development sequence or something else?"},
    {"id":"sequence-investors","title":"What 'could do' meant in the investor discussion","type":"Film-to-document comparison pending","account":"Compare the exact assertion with contemporaneous investor materials. Preserve the distinction between present capability and qualified future potential, and identify who heard which version when.","sources":["exhibit","sec"],"timecode":null,"verification":"Document leads identified; film scene not authenticated","question":"What are the full sentence, date, recipient, accompanying qualification and source evidence?"}
  ],
  "timeline": [
    {"id":"period-2013-15","date":"2013–2015","sort":"2013-01-01","kind":"Period alleged by SEC","event":"Investor fundraising and representations","meaning":"The SEC complaint concerns fundraising and alleged misrepresentations during this period, including technology and business performance. A later pitch or prototype cannot silently stand in for an earlier investor's information.","sources":["sec"],"gap":"Investor-by-investor dates, deck versions, disclosures and cash receipts remain to be reconstructed."},
    {"id":"period-2014","date":"2014","sort":"2014-01-01","kind":"SEC allegation about revenue","event":"Forecasts versus operations","meaning":"The SEC announcement contrasts claimed revenue expectations of more than $100 million with a little over $100,000 in revenue from operations. These figures are not a complete account of financing or spending.","sources":["sec-release"],"gap":"Separate a dated forecast, recognised revenue, cash receipts, valuation and expenditure. Do not put them on one scale as equivalent amounts."},
    {"id":"period-2016","date":"2016","sort":"2016-01-01","kind":"Study and company announcement; not one event date","event":"Independent service study; later platform presentation","meaning":"The JCI service comparison and the company's AACC announcement address different questions. Neither substitutes for contemporaneous proof of all earlier representations.","sources":["jci","minilab"],"gap":"Map publication dates, devices, assay menus and the exact versions represented to earlier investors."},
    {"id":"period-2018","date":"14 March 2018","sort":"2018-03-14","kind":"Civil action and settlement announcement","event":"SEC charges and Holmes/Theranos resolution","meaning":"The SEC announced charges and a resolution with Holmes and Theranos. Keep those allegations and settlement terms distinct from the later criminal case.","sources":["sec-release"],"gap":"Consult the actual complaint, consent and judgment for propositions that require more than the announcement."},
    {"id":"period-2022","date":"4 January 2022","sort":"2022-01-04","kind":"DOJ announcement of jury result","event":"Mixed criminal verdict reported","meaning":"The jury convicted on four investor-related counts; the reported result also includes acquittals and unresolved counts. It is not a verdict that every public allegation was true.","sources":["doj"],"gap":"Use count-specific court records for detailed legal analysis; do not infer intent for every communication from a headline."},
    {"id":"period-2026","date":"2026","sort":"2026-01-01","kind":"Film release/listing context","event":"The film revisits the history","meaning":"A later account, performance or reflection is evidence of that account. It does not by itself establish what a particular investor knew years earlier.","sources":["flc"],"gap":"Add reliable scene locators, contemporaneous source comparisons and clearly attributed participant explanations."}
  ]
}
